Prothena Corp. PLC | Ownership
Companies that own Prothena Corp. PLC
Woodford Investment Management Ltd.
11,924,614
29.93%
367,000
1.25%
06/30/2018
Fidelity Management & Research Co.
5,568,322
13.98%
-181,458
0.01%
06/30/2018
Scopia Capital Management LP
3,510,884
8.81%
3,510,884
0.92%
06/30/2018
SSgA Funds Management, Inc.
3,421,473
8.59%
1,674,378
0%
06/30/2018
Wellington Management Co. LLP
3,389,016
8.51%
64,902
0.01%
06/30/2018
BlackRock Fund Advisors
2,923,350
7.34%
237,928
0%
06/30/2018
Palo Alto Investors LP
1,103,325
2.77%
1,987
0.65%
06/30/2018
The Vanguard Group, Inc.
1,018,053
2.56%
336,369
0%
06/30/2018
Millennium Management LLC
842,164
2.11%
-29,145
0.02%
06/30/2018
T. Rowe Price Associates, Inc.
798,254
2%
-4,878,333
0%
06/30/2018
| Address |
77 Sir John Rogersons Quay
Dun Laoghaire Dublin 2
Ireland
|
|
Employees
|
- |
| Website |
http://www.prothena.com |
| Updated |
07/08/2019 |
| Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland. |
